scholarly journals Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country

2009 ◽  
pp. 643 ◽  
Author(s):  
Pandey ◽  
Mansher Singh ◽  
Nivedita Patni ◽  
Randeep Guleria
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Hospital Stay ◽  
Care Center ◽  
Tertiary Care ◽  
Tertiary Care Center ◽  
Medically Ill ◽  
Vein Thrombosis ◽  
Deep Vein ◽  
Medically Ill Patients

Variation in physician deep vein thrombosis prophylaxis attitudes and practices at an academic tertiary care center

2010 ◽  
Vol 30 (4) ◽  
pp. 419-425 ◽  
Author(s):  
Erin M. Galbraith ◽  
Bonnie M. Vautaw ◽  
Mary Grzybowski ◽  
Peter K. Henke ◽  
Tomas W. Wakefield ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Care Center ◽  
Tertiary Care ◽  
Thrombosis Prophylaxis ◽  
Tertiary Care Center ◽  
Attitudes And Practices ◽  
Vein Thrombosis ◽  
Deep Vein Thrombosis Prophylaxis ◽  
Deep Vein

scholarly journals Characteristics of Provoked Deep Vein Thrombosis in a Tertiary Care Center

2015 ◽  
Vol 62 (4) ◽  
pp. 1095
Author(s):  
Kirstyn Brownson ◽  
Anand Brahmandam ◽  
Nancy Huynh ◽  
Jesse Reynolds ◽  
Wassim Fares ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Care Center ◽  
Tertiary Care ◽  
Tertiary Care Center ◽  
Vein Thrombosis ◽  
Deep Vein

Deep vein thrombosis prophylaxis in a tertiary care center: An observational study

2016 ◽  
Vol 13 (1) ◽  
pp. 37-41
Author(s):  
Aparna Yerramilli ◽  
Shilpa Katta ◽  
Supriya Kidambi ◽  
Naveen Kumar Kotari ◽  
Santosh Devulapally ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Observational Study ◽  
Care Center ◽  
Tertiary Care ◽  
Thrombosis Prophylaxis ◽  
Tertiary Care Center ◽  
Vein Thrombosis ◽  
Deep Vein Thrombosis Prophylaxis ◽  
Deep Vein

More than one in two venous thromboembolism treated in French hospitals occurs during the hospital stays

2015 ◽  
Vol 31 (6) ◽  
pp. 390-396 ◽  
Author(s):  
Francois-André Allaert ◽  
Eric Benzenine ◽  
Catherine Quantin
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Venous Thromboembolism ◽  
Hospital Stay ◽  
Principal Diagnosis ◽  
Vein Thrombosis ◽  
Icd 10 ◽  
Hospital Stays ◽  
Deep Vein

Objective The objective was to describe the prevalence of venous thromboembolism, pulmonary embolism, and deep vein thrombosis among hospitalized patients and the percentages of those occurring during the hospital stays. Methods French DRG gave now the opportunity to investigate the frequency of venous thromboembolism occurring during the hospital stay. Statistics are issued from the national PMSI MCO databases encoded using the CIM10. Since 2010–2011 it is possible to differentiate the reason for hospital admission from the pathologies which secondly occurred. Any stay with the ICD-10 codes selected was considered as a hospital-occurred thrombosis unless it was the principal diagnosis of the first medical unit summary. To eliminate outpatient consultations or in day care, stays of <48 h were excluded. Results The results pertain to the 78,838,983 hospitalizations in France from 2005 to 2011 and on the 18,683,603 hospital stays in 2010–2011. The incidence of hospital stays came to 860,343 (1.09%) for venous thromboembolism, with 428,261 (0.543%) for deep vein thrombosis without pulmonary embolism and 432,082 (0.548%) for pulmonary embolism. It corresponds to an incidence of 189 per 100,000 inhabitants. Out of 100 hospital stays involving venous thromboembolism, for 40.3% venous thromboembolism was the cause of hospitalization whereas 59.7% can be considered to have occurred during hospital stay. These distributions are of 25.6 and 74.4% for deep vein thrombosis, respectively, 53.8 and 46.2% for pulmonary embolism. Conclusion The high proportion of hospital-occurred venous thromboembolism is an alarming situation that should question the quality of prevention and/or its effectiveness.

Lethal Trauma Pulmonary Embolism is a Black Swan Event in Patients at Risk for Deep Vein Thrombosis: An Evidence-Based Review

2017 ◽  
Vol 83 (4) ◽  
pp. 403-413 ◽  
Author(s):  
C. Michael Dunham ◽  
Gregory S. Huang
Keyword(s):  
At Risk ◽  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Confidence Interval ◽  
Hospital Stay ◽  
Trauma Patients ◽  
Black Swan ◽  
Vein Thrombosis ◽  
Patients At Risk ◽  
Deep Vein

We delineated the incidence of trauma patient pulmonary embolism (PE) and risk conditions by performing a systematic literature review of those at risk for deep vein thrombosis (DVT). The PE proportion was 1.4 per cent (95% confidence interval = 1.2–1.6) in at-risk patients. Of 10 conditions, PE was only associated with increased age (P < 0.01) or leg injury (P < 0.01; risk ratio = 1.6). As lower extremity DVT (LEDVT) proportions increased, mortality proportions (P = 0.02) and hospital stay (P = 0.0002) increased, but PE proportions did not (P = 0.13). LEDVT was lower with chemoprophylaxis (CP) (4.9%) than without CP (19.1%; P < 0.01). PEwas lower withCP (1.0%) than without CP (2.2%; P = 0.0004). Mortality was lower with CP (6.6%) than without CP (11.6%; P = 0.002). PE was similar with (1.2%) and without (1.9%; P = 0.19) mechanical prophylaxis (MP). LEDVT was lower with MP (8.5%) than without MP (12.2%; P = 0.0005). PE proportions were similar with (1.3%) and without (1.5%; P = 0.24) LEDVTsurveillance. Mortality was higher with LEDVTsurveillance (7.9%) than without (4.8%; P < 0.01). A PE mortality of 19.7 per cent (95% confidence interval = 18–22) 3 a 1.4 per cent PE proportion yielded a 0.28 per cent lethal PE proportion. As PE proportions increased, mortality (P = 0.52) and hospital stay (P = 0.13) did not. Of 176 patients with PE, 76 per cent had no LEDVT. In trauma patients at risk for DVT, PE is infrequent, has a minimal impact on outcomes, and death is a black swan event. LEDVTsurveillance did not improve outcomes. Because PE was not associated with LEDVT and most patients with PE had no LEDVT, preventing, diagnosing, and treating LEDVT may be ineffective PE prophylaxis.

scholarly journals Proximal Deep Vein Thrombosis and Pulmonary Embolism in COVID-19 Patients: A Systematic Review and Meta-Analysis Short Tittle: Venous Thromboembolism in COVID-19 Patients

2020 ◽  
Author(s):  
Gregoire Longchamp ◽  
Sara Manzocchi-Besson ◽  
Alban Longchamp ◽  
Marc Righini ◽  
Helia Robert-Ebadi ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Deep Vein Thrombosis ◽  
Venous Thromboembolism ◽  
Meta Analysis ◽  
Proximal Deep Vein Thrombosis ◽  
Primary Analysis ◽  
Thrombotic Risk ◽  
Medically Ill ◽  
Vein Thrombosis ◽  
Deep Vein

Abstract BACKGROUNGCOVID-19 appears to be associated with a high risk of venous thromboembolism (VTE). We aimed to systematically review and meta-analyze the risk of clinically relevant VTE in patients hospitalized for COVID-19. METHODSThis meta-analysis included original articles in English published from 01/01/2020 to 06/15/2020 in Pubmed/MEDLINE, Embase, Web of science, and Cochrane. Outcomes were major VTE, defined as any objectively diagnosed pulmonary embolism (PE) and/or proximal deep vein thrombosis (DVT). Primary analysis estimated the risk of VTE, stratified by acutely and critically ill inpatients. Secondary analyses explored the separate risk of proximal DVT and of PE; the risk of major VTE stratified by screening and by type of anticoagulation. RESULTSIn 33 studies (n=4’009 inpatients) with heterogeneous thrombotic risk factors, VTE incidence was 9% (95%CI 5-13%, I2=92.5) overall, and 21% (95%CI 14-28%, I2=87.6%) for patients hospitalized in the ICU. Proximal lower limb DVT incidence was 3% (95%CI 1-5%, I2= 87.0%) and 8% (95%CI 3-14%, I2=87.6%), respectively. PE incidence was 8% (95%CI 4-13%, I2=92.1%) and 17% (95%CI 11-25%, I2=89.3%), respectively. Screening and absence of anticoagulation were associated with a higher VTE incidence. When restricting to medically ill inpatients, the VTE incidence was 2% (95%CI 0-6%).CONCLUSIONSThe risk of major VTE among COVID-19 inpatients is high but varies greatly with severity of the disease. These findings reinforce the need for the use of thromboprophylaxis in all COVID-19 inpatients and for clinical trials testing different thromboprophylaxis regimens in subgroups of COVID-19 inpatients. TRIAL REGISTRATIONThe review protocol was registered in PROSPERO International Prospective Register of Systematic Reviews (CRD42020193369).

Sign in / Sign up

Export Citation Format

Share Document